חזרה לתוצאות החיפוש

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1

מצבים רפואיים

Breast Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • UCLA Jonsson Comp Cancer Center, Los Angeles, California, United States

    Contact: Study coordinator (Bhavisha Tailor) · BTailor@mednet.ucla.edu
    Contact: Principal Investigator (Aditya Bardia)

  • Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States

    Contact: Study coordinator (Beth Thomsen) · beth.thomsen@hoag.org
    Contact: Principal Investigator (Gary Ulaner)

  • University of Kansas Medical Center, Westwood, Kansas, United States

    Contact: Study coordinator (Jordan Rarden) · jrarden@kumc.edu · 913-588-6030
    Contact: Principal Investigator (Yiduo Hu)

  • University of Pennsylvania, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Erin Schubert) · erin.schubert@pennmedicine.upenn.edu · 215-573-6693
    Contact: Principal Investigator (Neil Taunk)

  • MD Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Afolashade O Bambe) · AOBambe@mdanderson.org
    Contact: Principal Investigator (Senthilkumar Damodaran)

  • Utah Intermountain Medical Center, Murray, Utah, United States

    Contact: Study coordinator (Becky Arroyo) · becky.arroyo@imail.org · 801-507-9333
    Contact: Principal Investigator (Dustin Boothe)

  • Novartis Investigative Site, Guangzhou, China

  • Novartis Investigative Site, Shanghai, China

  • Novartis Investigative Site, Tianjin, China

  • Novartis Investigative Site, Saint-Cloud, Hauts De Seine, France

  • Novartis Investigative Site, Bordeaux, France

  • Novartis Investigative Site, Clermont-Ferrand, France

  • Novartis Investigative Site, Saint-Herblain, France

  • Novartis Investigative Site, Strasbourg, France

  • Novartis Investigative Site, Cologne, North Rhine-Westphalia, Germany

  • Novartis Investigative Site, Erlangen, Germany

  • Novartis Investigative Site, Essen, Germany

  • Novartis Investigative Site, München, Germany

  • Novartis Investigative Site, Gliwice, Poland

  • Novartis Investigative Site, Porto, Portugal

  • Novartis Investigative Site, L'Hospitalet de Llobregat, Barcelona, Spain

  • Novartis Investigative Site, Barcelona, Spain

  • Novartis Investigative Site, Barcelona, Spain

  • Novartis Investigative Site, Madrid, Spain

  • Novartis Investigative Site, Madrid, Spain

מובילי המחקר

  • Novartis Pharmaceuticals

    Study Director

    Novartis Pharmaceuticals

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)פנייה לחוקר (אימייל)